Biotech Digest – INSM Reports Positive Data, MRK Gets EC Approval, LCI Receives FDA Approval
September 05, 2017 at 12:32 PM EDT
Oramed Pharmaceuticals reported the successful conclusion of its meeting with the FDA with regard to its drug candidate ORMD-0801. Insmed (INSM) stock jumped over 100 percent in the pre-market session.